China's new mAb institute

The launch of the Shanghai Institute for Advanced Immunochemical Studies marks China's first attempt to establish a center of antibody research on par with research centers in the U.S. and Europe. Although details are still sparse, the institute will identify targets and develop antibodies to treat cancer as well as infectious, autoimmune and metabolic diseases.

This month, the Chinese Academy of Sciences held a ceremony in Shanghai marking the launch of the Shanghai Institute for Advanced Immunochemical Studies (SIIS) by the University of Shanghai for Science and Technology (USST) and the Shanghai Advanced Research Institute. American researcher Richard Lerner was appointed head of the governing advisory board of the new institute...